Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Tumor Paint

Blaze Bioscience Inc.Request Info
Facebook Twitter LinkedIn Email Comments
Blaze Bioscience Inc. has announced the BLZ-100 tumor paint for real-time, high-resolution, intraoperative visualization of cancer cells.

The product consists of an optimized peptide and a fluorescent dye, emitting light in the NIR range for more precise, complete resection of cancer throughout surgery.

The investigative agent is in Phase 1 trials, with preclinical utility demonstrated on a range of cancer types.

Apr 2016

* Message:
(requirements, questions for supplier)
Your contact information
* First Name:
* Last Name:
* Email Address:
* Company:
Address 2:
Postal Code:
* Country:
Phone #:
Fax #:

Register or login to auto-populate this form:
Login Register
* Required

When you click "Send Request", we will record and send your personal contact information to Blaze Bioscience Inc. by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.
Productsfluorescent tumor agentBLZ-100tumor paintBlazeAmericasBiophotonicsimagingdiagnosticscancerSeattleWashington

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2021 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.